ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Transplant Surgery

Top Transplant Surgery Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LEWIS TEPERMAN M.D.

Transplant Surgery

8,572

$1.42M

327
143 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

23%
prescriptions for brand name drugs

$165
Average prescription price

SANDIP KAPUR M.D.

Transplant Surgery

1,175

$375K

98
31 are 65+

13%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

35%
prescriptions for brand name drugs

$319
Average prescription price

MARK STURDEVANT M.D.

Transplant Surgery

744

$149K

120
50 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

25%
prescriptions for brand name drugs

$200
Average prescription price

JIM KIM M.D.

Transplant Surgery

675

$117K

83
43 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

33%
prescriptions for brand name drugs

$173
Average prescription price

KISHORE IYER MD

Transplant Surgery

539

$106K

19
0 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

22%
prescriptions for brand name drugs

$196
Average prescription price

THOMAS DIFLO M.D.

Transplant Surgery

427

$75.4K

42
20 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

34%
prescriptions for brand name drugs

$177
Average prescription price

GLYN MORGAN M.D.

Transplant Surgery

328

$74.8K

37
18 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

30%
prescriptions for brand name drugs

$228
Average prescription price

MYRON SCHWARTZ MD

Transplant Surgery

256

$402K

74
67 are 65+

55%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

46%
prescriptions for brand name drugs

$1572
Average prescription price

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank